NX Development Corp | Finanzwire

Basculer en Français

9524	Companies
187323	Keywords
119356	Articles
100130	Press releases

Home
Companies
NX Development Corp

BRIEF

published on 06/21/2024 at 15:05, 1 year 5 months ago

NX Development Corp. Enrolls First Patient in OVA-302 Study After FDA Orphan Designation for Gleolan(R)

Gleolan NX Development Corp. OVA-302 Study FDA Orphan Designation
PRESS RELEASE

published on 06/21/2024 at 15:00, 1 year 5 months ago

NX Development Corp. Enrolls First Patient in OVA-302 Study After FDA Orphan Designation for Gleolan(R)
NX Development Corp. enrolls first patient in OVA-302 study for cancer management using Gleolan following FDA's Orphan Designation. CEO DeSena and Chairman Kosciessa express excitement for future programs

Gleolan NX Development Corp. OVA-302 Study Cancer Management Flourescence-guided Surgery
BRIEF

published on 03/05/2024 at 23:05, 1 year 9 months ago

NX Development Corp. Awarded Orphan-Drug Designation for Gleolan in Ovarian Cancer Treatment

FDA NX Development Corp Orphan-Drug Designation Gleolan Ovarian Cancer
PRESS RELEASE

published on 03/05/2024 at 23:00, 1 year 9 months ago

NX Development Corp. is Granted Orphan-Drug Designation Status by US FDA for Gleolan(R) in Ovarian and Related Cancers
NX Development Corp. has achieved orphan-drug status from the FDA for Gleolan, aiding in the visualization of ovarian tumors during surgery. The milestone highlights innovation in cancer care and surgery

FDA Cancer Care Gleolan NX Development Corp. Orphan-drug Status

Accesswire

Published on 12/15/2025 at 09:01, 1 hour 46 minutes ago

Apex Discovers Mineralized Carbonatite at its Lac Le Moyne Project, Québec
Published on 12/14/2025 at 23:00, 11 hours 47 minutes ago

Fortescue to Acquire Alta Copper for C$1.40 per Share
Published on 12/13/2025 at 02:00, 2 days 8 hours ago

Battery X Metals Announces Confidential Submission of Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 12/13/2025 at 00:13, 2 days 10 hours ago

Prospect Ridge Announces Non-Brokered Private Placement
Published on 12/12/2025 at 23:05, 2 days 11 hours ago

ReelTime's RLTR Stock Surges Past AI Giants Following LG Smart TV Debut of Reel Intelligence

View all ACCESSWIRE

EQS Group

Published on 12/15/2025 at 10:30, 16 minutes ago

Original-Research: Verve Group SE (von GBC AG): BUY
Published on 12/15/2025 at 10:30, 17 minutes ago

EQS-Adhoc: Gothaer Allgemeine Versicherung AG: BarmeniaGothaer closes its first financial year 2025 with a very good result
Published on 12/15/2025 at 10:15, 32 minutes ago

Now Is Yours: Huawei Rolls Out Mate X7 Alongside a New Lineup of Innovative Products
Published on 12/15/2025 at 10:09, 38 minutes ago

FAVEOS SE concludes strategic framework agreements with leading battery optimizers enspired and Entrix
Published on 12/15/2025 at 10:05, 42 minutes ago

Voltage Energy Secures Industry's First Full-System 2kV EBOS Certification from UL Solutions

Les Echos

Published on 12/12/2025 at 18:00, 2 days 16 hours ago

Disclosure of trading in own shares between November 24th and November 28th, 2025
Published on 12/12/2025 at 09:15, 3 days 1 hour ago

CHANGE IN THE SHARE CAPITAL
Published on 12/11/2025 at 19:23, 3 days 15 hours ago

Eiffage is joining the CAC 40 index
Published on 12/11/2025 at 08:30, 4 days 2 hours ago

Edenred and Daimler Truck join forces to accelerate the rollout of charging infrastructure for electric trucks in Europe
Published on 12/11/2025 at 08:29, 4 days 2 hours ago

Schneider Electric hosts a Capital Markets Day for investors and financial analysts

View all LES ECHOS COMFI WIRE